AAAAAA

   
Results: 1-7 |
Results: 7
Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node-negative breast cancer
Authors: Colleoni, M Gelber, S Coates, AS Castiglione-Gertsch, M Gelber, RD Price, K Rudenstam, CM Lindtner, J Collins, J Thurlimann, B Holmberg, SB Cortes-Funes, H Simoncini, E Murray, E Fey, M Goldhirsch, A
Citation: M. Colleoni et al., Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node-negative breast cancer, J CL ONCOL, 19(21), 2001, pp. 4141-4149
Clinical relevance of single item quality of life indicators in cancer clinical trials
Authors: Bernhard, J Sullivan, M Hurny, C Coates, AS Rudenstam, CM
Citation: J. Bernhard et al., Clinical relevance of single item quality of life indicators in cancer clinical trials, BR J CANC, 84(9), 2001, pp. 1156-1165
Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: The International Breast Cancer Study Group Trial VII
Authors: Crivellari, D Bonetti, M Castiglione-Gertsch, M Gelber, RD Rudenstam, CM Thurlimann, B Price, KN Coates, AS Hurny, C Bernhard, J Lindtner, J Collins, J Senn, HJ Cavalli, F Forbes, J Gudgeon, A Simoncini, E Cortes-Funes, H Veronesi, A Fey, M Goldhirsch, A
Citation: D. Crivellari et al., Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: The International Breast Cancer Study Group Trial VII, J CL ONCOL, 18(7), 2000, pp. 1412-1422
Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors
Authors: Colleoni, M Bonetti, M Coates, AS Castiglione-Gertsch, M Gelber, RD Price, K Rudenstam, CM Lindtner, J Collins, J Thurlimann, B Holmberg, S Veronesi, A Marini, G Goldhirsch, A
Citation: M. Colleoni et al., Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors, J CL ONCOL, 18(3), 2000, pp. 584-590
Identifying breast cancer patients at high risk for bone metastases
Authors: Colleoni, M O'Neill, A Goldhirsch, A Gelber, RD Bonetti, M Thurlimann, B Price, KN Castiglione-Gertsch, M Coates, AS Lindtner, J Collins, J Senn, HJ Cavalli, F Forbes, J Gudgeon, A Simoncini, E Cortes-Funes, H Veronesi, A Fey, M Rudenstam, CM
Citation: M. Colleoni et al., Identifying breast cancer patients at high risk for bone metastases, J CL ONCOL, 18(23), 2000, pp. 3925-3935
Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?
Authors: Aebi, S Gelber, S Castiglione-Gertsch, M Gelber, RD Collins, J Thurlimann, B Rudenstam, CM Lindtner, J Crivellari, D Cortes-Funes, H Simoncini, E Werner, ID Coates, AS Goldhirsch, A
Citation: S. Aebi et al., Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?, LANCET, 355(9218), 2000, pp. 1869-1874
Efficacy of pamidronate in breast cancer with bone metastases: A randomized, double-blind placebo-controlled multicenter study
Authors: Hultborn, R Gundersen, S Ryden, S Holmberg, E Carstensen, J Wallgren, UB Killany, S Andreassen, L Carlsson, G Fahl, N Hatschek, T Sommer, HH Hessman, Y Hornmark-Stenstam, B Johnsborg, S Klepp, R Laino, R Niklasson, LG Rudenstam, CM Sundbeck, A Soderberg, M Tejler, G
Citation: R. Hultborn et al., Efficacy of pamidronate in breast cancer with bone metastases: A randomized, double-blind placebo-controlled multicenter study, ANTICANC R, 19(4C), 1999, pp. 3383-3392
Risultati: 1-7 |